Carlsmed, Inc. (CARL) stock
CARLNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 5/30118% above fair value
$17.74+0.39 (+2.25%)
Close on Nov 17, 2026Market cap $484.35MP/E –Yield –
Carlsmed price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
Carlsmed's price to sales ratio was 8.0× on Nov 11, 2026, against 9.7× a year earlier.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 8.0× | +0.7 |
| 2025 | Dec 31, 2025 | 7.3× | – |
See a number that looks wrong?